Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Delobel

Showing results (21-30 of 160) with videos related to

Pageof 16
Sort By:
Fundamental & Clinical Pharmacology|October 28, 2020
Outcome of patients hospitalized for COVID-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: results of the ACE-CoV studyMargaux Lafaurie, Guillaume Martin-Blondel, Pierre Delobel, et al.
Medecine Et Maladies Infectieuses|May 18, 2019
Olecranon bursitis secondary to Mycobacterium europaeum infection in a patient receiving immunosuppressive drugs for rheumatoid arthritisMarine Dutertre, Pierre Delobel, Bruno Marchou, et al.
Journal of Travel Medicine|March 3, 2022
Two-year immunogenicity of a pre-exposure rabies vaccination administered as a two-dose scheduleLaurie Windels, Véronique Naneix-Laroche, Christophe Pasquier, et al.
BMC Pharmacology & Toxicology|March 12, 2021
Impact of previous exposure to systemic corticosteroids on unfavorable outcome in patients hospitalized for COVID-19Margaux Lafaurie, Guillaume Martin-Blondel, Pierre Delobel, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 10, 2025
From neglected to notoriety: a review of Mpox clinical features, virology, epidemiology, treatment and prevention strategiesClément Viguier, Pierre Delobel, François-Xavier Lescure, et al.
Infectious Diseases Now|October 4, 2021
Comparison of the first and second waves of coronavirus disease in Toulouse, FranceAurelie Jourdes, Margaux Lafaurie, Guillaume Moulis, et al.
AIDS (London, England)|September 7, 2019
IL-7 immunotherapy for progressive multifocal leukoencephalopathy in a patient with already controlled HIV-1 infection on antiretroviral therapyMarie Guille, Stella Rousset, Fabrice Bonneville, et al.
AIDS (London, England)|February 1, 2019
HIV-1 escape in the central nervous system on elvitegravir-based antiretroviral therapyClaire Guerveno, Stéphanie Raymond, David Metsu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 15, 2005
R5 to X4 switch of the predominant HIV-1 population in cellular reservoirs during effective highly active antiretroviral therapyPierre Delobel, Karine Sandres-Sauné, Michelle Cazabat, et al.
Annals of Hematology|April 27, 2016
Use of rifampin for treatment of disseminated tuberculosis in a patient with primary myelofibrosis on ruxolitinibBenoit Branco, David Metsu, Marine Dutertre, et al.
Pageof 16

Showing results (21-30 of 160) with videos related to

Sort By:
Pageof 16
Fundamental & Clinical Pharmacology|October 28, 2020
Outcome of patients hospitalized for COVID-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: results of the ACE-CoV studyMargaux Lafaurie, Guillaume Martin-Blondel, Pierre Delobel, et al.
Medecine Et Maladies Infectieuses|May 18, 2019
Olecranon bursitis secondary to Mycobacterium europaeum infection in a patient receiving immunosuppressive drugs for rheumatoid arthritisMarine Dutertre, Pierre Delobel, Bruno Marchou, et al.
Journal of Travel Medicine|March 3, 2022
Two-year immunogenicity of a pre-exposure rabies vaccination administered as a two-dose scheduleLaurie Windels, Véronique Naneix-Laroche, Christophe Pasquier, et al.
BMC Pharmacology & Toxicology|March 12, 2021
Impact of previous exposure to systemic corticosteroids on unfavorable outcome in patients hospitalized for COVID-19Margaux Lafaurie, Guillaume Martin-Blondel, Pierre Delobel, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 10, 2025
From neglected to notoriety: a review of Mpox clinical features, virology, epidemiology, treatment and prevention strategiesClément Viguier, Pierre Delobel, François-Xavier Lescure, et al.
Infectious Diseases Now|October 4, 2021
Comparison of the first and second waves of coronavirus disease in Toulouse, FranceAurelie Jourdes, Margaux Lafaurie, Guillaume Moulis, et al.
AIDS (London, England)|September 7, 2019
IL-7 immunotherapy for progressive multifocal leukoencephalopathy in a patient with already controlled HIV-1 infection on antiretroviral therapyMarie Guille, Stella Rousset, Fabrice Bonneville, et al.
AIDS (London, England)|February 1, 2019
HIV-1 escape in the central nervous system on elvitegravir-based antiretroviral therapyClaire Guerveno, Stéphanie Raymond, David Metsu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 15, 2005
R5 to X4 switch of the predominant HIV-1 population in cellular reservoirs during effective highly active antiretroviral therapyPierre Delobel, Karine Sandres-Sauné, Michelle Cazabat, et al.
Annals of Hematology|April 27, 2016
Use of rifampin for treatment of disseminated tuberculosis in a patient with primary myelofibrosis on ruxolitinibBenoit Branco, David Metsu, Marine Dutertre, et al.
Pageof 16